National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 84345 [2023-26630]
Download as PDF
<![CDATA[
84345
Federal Register / Vol. 88, No. 232 / Tuesday, December 5, 2023 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Form name
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
Focus Group Participant Characteristics Form (All Phases)
120
1
120
0.08
9.6
Total ..............................................................................
368
........................
976
........................
325.8
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023–26586 Filed 12–4–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
Biophysics and Biochemistry
Fellowship Review, December 13, 2023,
11:00 a.m. to December 13, 2023, 05:00
p.m., National Institutes of Health,
Rockledge II 6701 Rockledge Drive,
Bethesda, MD 20892 which was
published in the Federal Register on
November 28, 2023, 88 FR 83143, Doc
2023–26127.
This meeting is being amended to
change the meeting panel name from
‘‘Biophysics and Biochemistry
Fellowship Review’’ to ‘‘Topics in
Biophysics and Biochemistry’’. The
meeting is closed to the public.
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondent
Dated: November 30, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–26667 Filed 12–4–23; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:35 Dec 04, 2023
Jkt 262001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Institutional
Network Applications for Promoting Kidney,
Urologic, and Hematologic Research Training
(U2C–TL1).
Date: March 26–27, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jason D. Hoffert, Ph.D.,
Scientific Review Officer, Review Branch,
Division of Extramural Activities, NIDDK,
National Institutes of Health, Room 7343,
6707 Democracy Boulevard, Bethesda, MD
20892, 301–496–9010, hoffertj@
niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neurological Disorders and Multiple
Sclerosis.
Date: December 18, 2023.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aleksey Gregory
Kazantsev, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 5201, Bethesda, MD 20892, (301) 435–
1042, aleksey.kazantsev@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 29, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: November 30, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–26630 Filed 12–4–23; 8:45 am]
[FR Doc. 2023–26669 Filed 12–4–23; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
E:\FR\FM\05DEN1.SGM
05DEN1
]]>Agencies
[Federal Register Volume 88, Number 232 (Tuesday, December 5, 2023)]
[Notices]
[Page 84345]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-26630]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Institutional Network
Applications for Promoting Kidney, Urologic, and Hematologic
Research Training (U2C-TL1).
Date: March 26-27, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institutes of Health, NIDDK, Democracy II, Suite
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Jason D. Hoffert, Ph.D., Scientific Review
Officer, Review Branch, Division of Extramural Activities, NIDDK,
National Institutes of Health, Room 7343, 6707 Democracy Boulevard,
Bethesda, MD 20892, 301-496-9010, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: November 29, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-26630 Filed 12-4-23; 8:45 am]
BILLING CODE 4140-01-P
